Comparisonsmaster
FDA-Approved Weight Management Treatments in 2022
Related Topics (Sponsored Ads):
This is partly because high-calorie food products are easy to find and cheap to buy. Finding suitable ways to prevent and treat obesity can make a huge difference in the length and quality of life for those who have it.
Treatments for Obesity such as the popular medication – Liraglutide, are giving severely overweight Americans renewed hope.
Phentermine/topiramate, naltrexone/bupropion, liraglutide, and semaglutide all seem to help people lose weight, and semaglutide may be the most effective of them all currently. This group of medicines just recently got the green light from the FDA. Though, it’s still very difficult to establish treatment guidelines because there aren’t enough long-term studies that look at how safe and effective obesity drugs are over time.
Patients who are dangerously obese still need weight-loss treatments, and the benefits of losing fat mass may be more important than the possible side effects of these medications. Clinicians are now being instructed to provide their patients whichever FDA-approved drug therapy they think will help them the most in their particular situation. Continue reading to compare the different treatments that the FDA recently approved to help people with severe weight problems, how they are given, and how they benefit obese people overall.
This is partly because high-calorie food products are easy to find and cheap to buy. Finding suitable ways to prevent and treat obesity can make a huge difference in the length and quality of life for those who have it.
Treatments for Obesity such as the popular medication – Liraglutide, are giving severely overweight Americans renewed hope.
Phentermine/topiramate, naltrexone/bupropion, liraglutide, and semaglutide all seem to help people lose weight, and semaglutide may be the most effective of them all currently. This group of medicines just recently got the green light from the FDA. Though, it’s still very difficult to establish treatment guidelines because there aren’t enough long-term studies that look at how safe and effective obesity drugs are over time.
Patients who are dangerously obese still need weight-loss treatments, and the benefits of losing fat mass may be more important than the possible side effects of these medications. Clinicians are now being instructed to provide their patients whichever FDA-approved drug therapy they think will help them the most in their particular situation. Continue reading to compare the different treatments that the FDA recently approved to help people with severe weight problems, how they are given, and how they benefit obese people overall.
The World Health Organization Reports That 1 Billion People Worldwide Suffer from Obesity
In 1760, an English doctor named Malcolm Flemyng was the first person to call obesity a disease. Obesity has a bad reputation, but if it were seen as a disease instead of a social factor, the general public might change how they feel about it. Those who are overweight have a body mass index (BMI) of 25 or more, while those who are obese have a BMI of 30 or more. Obesity is a worldwide problem that is still getting worse. It affects billions of people all over the world.
WHO says that more than a billion people around the world are overweight, which puts them at greater risk of having their health get worse. Obesity has been linked to diabetes mellitus, heart disease, high blood pressure, stroke, less fertility in women, mental health problems, worse results from COVID-19, a higher risk of cancer, and ultimately a shorter life span.
Semaglutide is Emerging as a Promising Pharmacotherapy for Weight Management
Technology developments, a more sedentary lifestyle, and easier availability to high-calorie meals have all contributed to the rising incidence of obesity. Genetic factors are also significant. As a result, there are many different ways to treat obesity, including lifestyle changes, medication, and bariatric surgery. Additionally, pharmacotherapy might serve as a transitional measure between lifestyle changes and bariatric surgery.
A significantly large portion of the world’s population might have their quality of life enhanced by effective prevention and management, which could avert millions of deaths. For long-term weight reduction usage in 2022, the FDA has authorized five drugs: Orlistat, Phentermine-topiramate, Naltrexone-bupropion, Liraglutide, and Semaglutide. The latter of these medications is proving to be the more effective, long term, in the limited amount of studies that have been carried out on these medicines.
Semaglutide, Unlike The Popular Liraglutide, Needs Only Be Injected Once a Week
Semaglutide has been shown in studies to be significantly more effective for achieving and maintaining weight loss than the popular medication Liraglutide. The downside is the subcutaneous route of administration which might be inconvenient for some patients, although weekly dosing makes it a bit more convenient than daily subcutaneous dosing of Liraglutide.
Patients that can tolerate Semaglutide, find it can be added to behavioral therapy and diet modification for achieving and maintaining significant weight loss in the obese/overweight population. The possible superiority of Semaglutide with a similar risk of adverse effects makes it an excellent choice of drug for the management of obesity in the patient population that can take subcutaneous medication.
Semaglutide Can Be Administered At Home Through An Injection Pen
Semaglutide is administered subcutaneously in the abdomen, thighs, or upper arm. Use a new body region each time you administer an injection to yourself. Keep note of where each injection is administered to ensure a rotation of body locations. Examine the ink in the pen. It must be transparent and colorless. If it is hazy, discolored, or contains particles, do not use it.
Always use a fresh needle each time you inject medication, and never, under any circumstances, share injection pens. As sharing needles or pens might result in the spread of illness, it is unsafe for many individuals to use the same pen. Semaglutide must be injected weekly on the same day, at any time of day, with or without food.
Dosage instructions:
Brand name: Wegovy
Adults, At first, 0.25 milligrams (mg) injected under the skin once a week for 4 weeks. Your doctor may increase your dose every 4 weeks. However the dose is usually not more than 2.4 mg once a week.
